Atria Wealth Solutions’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$10.3M Sell
55,034
-82,671
-60% -$15.4M 0.23% 98
2025
Q1
$28.9M Sell
137,705
-6,769
-5% -$1.32M 0.35% 53
2024
Q4
$25.7M Sell
144,474
-11,922
-8% -$2.19M 0.28% 73
2024
Q3
$30.9M Sell
156,396
-1,591
-1% -$297K 0.34% 52
2024
Q2
$27.1M Sell
157,987
-10,459
-6% -$1.73M 0.3% 58
2024
Q1
$30.7M Buy
168,446
+21,062
+14% +$3.63M 0.35% 47
2023
Q4
$22.8M Buy
147,384
+1,816
+1% +$265K 0.29% 71
2023
Q3
$21.7M Buy
145,568
+8,923
+7% +$1.31M 0.3% 69
2023
Q2
$18.4M Buy
136,645
+828
+0.6% +$121K 0.25% 87
2023
Q1
$21.6M Sell
135,817
-12,823
-9% -$1.96M 0.32% 70
2022
Q4
$24M Buy
148,640
+337
+0.2% +$51.7K 0.39% 51
2022
Q3
$19.9M Buy
148,303
+23,619
+19% +$3.39M 0.34% 58
2022
Q2
$19.1M Buy
124,684
+16,310
+15% +$2.49M 0.38% 67
2022
Q1
$17.6M Buy
+108,374
New +$15.7M 0.29% 72

Other funds holding ABBV